OXYTOCIN INJECTION 10IU/1ML 10'S
OXYTOCIN INJECTION 10IU/1ML 10'S
What it does
Active ingredient 10's is used to treat various conditions. Please consult a healthcare professional for specific details about its uses.
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:20:55 · updated 2026-08-03 02:07:08
Drug Interactions
1Unknown (1)
Oxytocin - additive effect
Misoprostol can cause uterine contractions, as can oxytocin; concurrent use might increase the risk of developing this effect. Avoid and for 4 hours after stopping misoprostol. Mitomycin → see TABLE 1
Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: exact
About 10's
Active ingredient 10's is used to treat various conditions. Please consult a healthcare professional for specific details about its uses.
How it works
The exact way this ingredient works in the body is not specified.
Who it's for
This medication may be suitable for adults and children depending on the specific condition, but always check with a healthcare professional.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About oxytocin
Oxytocin is a hormone used to help with childbirth and other related conditions.
What it treats
- inducing labor
- controlling bleeding after childbirth
- promoting milk production
How it works
Oxytocin helps stimulate uterine contractions during labor and encourages milk flow during breastfeeding.
Who it's for
This medicine is typically used for pregnant women during labor or after delivery.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: Oxytocin
BNF-referencedOxytocin is a nonapeptide hormone produced in the hypothalamus and secreted by the posterior pituitary gland. It plays a crucial role in childbirth and lactation by stimulating uterine contractions and milk ejection during breastfeeding. Additionally, oxytocin has significant effects on social behaviors, emotional bonding, and various metabolic and cardiovascular functions. Its pharmacological properties mirror those of naturally occurring oxytocin, making it useful for medically managing labor and postpartum complications.
Indications
- Induction of labor
- Management of postpartum hemorrhage
- Facilitation of uterine contraction during labor
Dosage
Children: Dosing information for pediatric use of oxytocin is not provided in the BNF. Consult the BNF for Children for appropriate guidance.
Adults: For induction of labor, oxytocin is typically administered intravenously, starting with a low dose and adjusted based on uterine response. Refer to the BNF for specific dosing guidelines.
Mechanism of action
Oxytocin induces uterine contractions by binding to oxytocin receptors on the myometrium, which are significantly upregulated during pregnancy. This binding triggers a cascade that increases intracellular calcium in uterine myofibrils, leading to enhanced contraction strength and frequency. The hormone's secretion is regulated by a positive feedback mechanism, where the pressure of the fetus against the cervix stimulates further release of oxytocin, thus facilitating labor.
Pharmacodynamics
As a pleiotropic hormone, oxytocin influences numerous physiological processes beyond childbirth, including lactation, metabolism, cardiovascular function, and social behaviors. Its receptors are widely distributed, including in the central nervous system, where they affect emotional and social functions. Oxytocin's action is characterized by its ability to modulate both reproductive and non-reproductive behaviors, suggesting its broad physiological impact.
Pharmacokinetics
Oxytocin is administered either intravenously or intramuscularly, with rapid absorption and onset of action. Its half-life is relatively short, generally around 3 to 5 minutes, necessitating continuous infusion or repeated dosing to maintain effective levels during labor. The distribution volume is extensive, and it is metabolized in the liver and kidneys. Exogenous oxytocin exhibits similar pharmacokinetics to the endogenous form, ensuring effective therapeutic outcomes.
Contra-indications
- Severe fetal distress
- Hypersensitivity to oxytocin
- Uterine hypertonicity
- Certain cardiovascular disorders
- Active genital herpes infection
- Placenta previa
Adverse effects
- Nausea
- Vomiting
- Uterine hypertonicity
- Water retention
- Hypotension
- Tachycardia
- Allergic reactions
Interactions
- Misoprostol may have an additive effect when used with oxytocin
Precautions
- Use with caution in patients with pre-existing cardiovascular conditions
- Monitor for excessive uterine contractions
- Caution in patients with a history of uterine surgery
- Consider the risk of water intoxication with large doses
Pregnancy
Oxytocin is used during pregnancy for induction of labor and to prevent postpartum hemorrhage.
Breast-feeding
Oxytocin is excreted in breast milk, but its effects on a nursing infant are not well established. Monitor for potential effects.
Storage
Store in a refrigerator at 2-8 degrees Celsius. Protect from light and keep out of reach of children.
Formulations
- Injection solution
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: Oxytocin
PubChem CID 439302Molecular formula: C43H66N12O12S2
Mechanism of action
Oxytocin plays a vital role in labour and delivery. The hormone is produced in the hypothalamus and is secreted from the paraventricular nucleus to the posterior pituitary where it is stored. It is then released in pulses during childbirth to induce uterine contractions. The concentration of oxytocin receptors on the myometrium increases significantly during pregnancy and reaches a peak in early labor. Activation of oxytocin receptors on the myometrium triggers a downstream cascade that leads to increased intracellular calcium in uterine myofibrils which strengthens and increases the frequency of uterine contractions. In humans, most hormones are regulated by negative feedback; however, oxytocin is one of the few that is regulated by positive feedback. The head of the fetus pushing on the cervix signals the release of oxytocin from the posterior pituitary of the mother. Oxytocin then travels to the uterus where it stimulates uterine contractions. The elicited uterine contractions will then stimulate the release of increasing amounts of oxytocin. This positive feedback loop will continue until parturition. Since exogenously administered and endogenously secreted oxytocin result in the same effects on the female reproductive system, synthetic oxytocin may be used in specific instances during the antepartum and postpartum period to induce or improve uterine contractions. The pharmacologic and clinical properties of oxytocin are identical with those of naturally occurring oxytocin principle of the posterior lobe of pituitary. Oxytocin exerts a selective action on the smooth musculature of the uterus, particularly toward the end of pregnancy, during labor, and immediately following delivery. Oxytocin stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of the uterine musculature. Oxytocin indirectly stimulates contraction of uterine smooth muscle by increasing the sodium permeability of uterine myofibrils. High estrogen concentrations lower the threshold for uterine response to oxytocin. Uterine response to oxytocin increases with the duration of pregnancy and is greater in patients who are in labor than those not in labor; only very large doses elicit contractions in early pregnancy. Contractions produced in the term uterus by oxytocin are similar to those occurring during spontaneous labor. In the term uterus, oxytocin increases the amplitude and frequency of uterine contractions which in turn tend to decrease cervical activity producing dilation and effacement of the cervix and to transiently impede uterine blood flow. Oxytocin contracts myoepithelial cells surrounding the alveoli of the breasts, forcing milk from the alveoli into the larger ducts and thus facilitating milk ejection. The drug possesses no galactopoietic properties. Oxytocin produces vasodilation of vascular smooth muscle, increasing renal, coronary, and cerebral blood flow. Blood pressure is usually unchanged, but following iv administration of very large doses or undiluted solutions, blood pressure may decrease transiently, and tachycardia and an increase in cardiac output may be reflexly induced. Any initial fall in blood pressure is usually followed by a small but sustained increase in blood pressure. In contrast to vasopressin, oxytocin has minimal antidiuretic effects; however, water intoxication may occur when oxytocin is administered with an excessive volume of electrolyte-free iv fluids and/or at too rapid a rate. For more Mechanism of Action (Complete) data for Oxytocin (15 total), please visit the HSDB record page.
Pharmacodynamics
Oxytocin is a nonapeptide, pleiotropic hormone that exerts important physiological effects. It is most well known to stimulate parturition and lactation, but also has important physiological influences on metabolic and cardiovascular functions, sexual and maternal behaviour, pair bonding, social cognition, and fear conditioning. It is worth noting that oxytocin receptors are not limited to the reproductive system but can be found in many peripheral tissues and in central nervous system structures including the brain stem and amygdala.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- OXYCIN-10 10IU/ML INJECTION
- OXYNIR 10IU INJECTION
- OXYTOCIN 10IU/ML INJECTION
- OXYTOCIN 10MG/ML INJECTION
- OXYTOCIN 10MG/ML INJECTION
- OXYTOCIN 10iu/ML INJECTION
- BEDICIN INJECTION (Each ml contains Oxytocin 10iu/ml Oxytocin 10iu/ml) · Pharmax India
- KYTOCIN INJECTION · Bharat Parenterals
- OXTOCIN SOLUTION FOR INJECTION (Each ml contains Oxytocin 10iu) · Vetox Healthcare
- OXYTOCIN INJECTION BP · Atlantic Lifesciences
- Oxytocin Injection (Each ml contains Oxytocin 10iu) · Atlantic Lifesciences
- PROMPTIN INJECTION · Sterile Gene Lifesciences
- Oxytocin - 20 injection 50 ml · Interchemie
- Oxytocin Injection (Oxytocin Injection BP 10 IU/ml) · Umedica Laboratories
- SANTOCYN® Injection · Pt Sanbe Farma
- Syntocinon 10 IU Injection (oxytocin 10 IU/ml) · Mylan Laboratories
- TOSININ · Steril-gene Life Sciences
- Tosinin 5 Injection · Steril-Gene Life Sciences